Extracellular Vesicles from Mesenchymal Stem Cells: Towards Novel Therapeutic Strategies for Neurodegenerative Diseases
International Journal of Molecular Sciences · 02.02.2023 · 24 (3) · 2917
DOI: 10.3390/ijms24032917 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.02.2023. Verfasst von Ermanna Turano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Extracellular Vesicles, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Cariverona, Cariverona project.
Abstract (Originalsprache)
Neurodegenerative diseases are fatal disorders of the central nervous system (CNS) which currently lack effective treatments. The application of mesenchymal stem cells (MSCs) represents a new promising approach for treating these incurable disorders. Growing evidence suggest that the therapeutic effects of MSCs are due to the secretion of neurotrophic molecules through extracellular vesicles. The extracellular vesicles produced by MSCs (MSC-EVs) have valuable innate properties deriving from parental cells and could be exploited as cell-free treatments for many neurological diseases. In particular, thanks to their small size, they are able to overcome biological barriers and reach lesion sites inside the CNS. They have a considerable pharmacokinetic and safety profile, avoiding the critical issues related to the fate of cells following transplantation. This review discusses the therapeutic potential of MSC-EVs in the treatment of neurodegenerative diseases, focusing on the strategies to further enhance their beneficial effects such as tracking methods, bioengineering applications, with particular attention to intranasal delivery as a feasible strategy to deliver MSC-EVs directly to the CNS in an effective and minimally invasive way. Current progresses and limiting issues to the extent of the use of MSC-EVs treatment for human neurodegenerative diseases will be also revised.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
- Neurology Unit, Azienda Ospedaliera Universitaria Integrata Verona, 37124 Verona, Italy.
ORCID-Profile: Ermanna Turano, Ilaria Scambi
Förderung
- Fondazione Cariverona
- Cariverona project
Zitieren
APA
Turano, E., Scambi, I., Virla, F., Bonetti, B., & Mariotti, R. (2023). Extracellular Vesicles from Mesenchymal Stem Cells: Towards Novel Therapeutic Strategies for Neurodegenerative Diseases. International Journal of Molecular Sciences, 24(3), 2917. https://doi.org/10.3390/ijms24032917
Vancouver
Turano E, Scambi I, Virla F, Bonetti B, Mariotti R. Extracellular Vesicles from Mesenchymal Stem Cells: Towards Novel Therapeutic Strategies for Neurodegenerative Diseases. International Journal of Molecular Sciences. 2023;24(3):2917. doi:10.3390/ijms24032917
BibTeX
@article{Turano2023,
author = {Turano, Ermanna and Scambi, Ilaria and Virla, Federica and Bonetti, Bruno and Mariotti, Raffaella},
title = {Extracellular Vesicles from Mesenchymal Stem Cells: Towards Novel Therapeutic Strategies for Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2917},
doi = {10.3390/ijms24032917}
}
EUVIMED